Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [1]
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2843960 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Angiopoietin 2 (ANGPT2) (AA 404-432), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 404-432, C-Term
- Antibody clone number
- RB17789
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models.
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.
Alamo P, Gallardo A, Di Nicolantonio F, Pavón MA, Casanova I, Trias M, Mangues MA, Lopez-Pousa A, Villaverde A, Vázquez E, Bardelli A, Céspedes MV, Mangues R
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2015 Feb;29(2):464-76
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2015 Feb;29(2):464-76
Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models.
Alamo P, Gallardo A, Pavón MA, Casanova I, Trias M, Mangues MA, Vázquez E, Villaverde A, Mangues R, Céspedes MV
Disease models & mechanisms 2014 Mar;7(3):387-96
Disease models & mechanisms 2014 Mar;7(3):387-96
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.
Morrissey C, Dowell A, Koreckij TD, Nguyen H, Lakely B, Fanslow WC, True LD, Corey E, Vessella RL
The Prostate 2010 Dec 1;70(16):1799-808
The Prostate 2010 Dec 1;70(16):1799-808
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS